EVALUATION OF CLINICAL EFFICIENCY OF RESTRICTIVE TACTICS OF ANTIBACTERIAL THERAPY IN CASE OF UNPROVED INFECTION IN NEONATAL INTENSIVE CARE DEPARTMENT
https://doi.org/10.21292/2078-5658-2016-13-6-54-58
Abstract
Goal of the article: comparative analysis of correlation of liberal and restrictive tactics of anti-bacterial therapy (ABT) in newborns with respiratory distress syndrome (RDSS) and suspected congenial pneumonia with drug resistant bacterial population in neonatal intensive care department (ICD). Methods. The study was designed as prospective, controlled, one-center, non-randomized. Enrollment criteria were the following: gestational age of 25-32 weeks, body weight of 1001-2499 g., RDSS or suspected congenial pneumonia, artificial pulmonary ventilation (APV) from the first day of birth, procalcitonin level tests. The study lasted from 01.01.2015 to 26.12.2015. 697 newborns were included into the study. Restrictive ABT was used in the treatment group (n=515), prescription of antibiotics for preventive purposes was used in the comparison group (n=182). Samples were collected from sterile cavities of the host - tracheal aspirate, content of urinary bladder and stomach. Results. 2535 gram negative and 299 gram positive isolates of pathogenic microorganisms were examined. Kl. pneumonia was the most prevalent among gram negative microorganisms (1 202 isolates, 47.4% of all strains), St. aureus was the most prevalent among gram positive bacteria (207 isolates). Conclusions. Restrictive ABT tactics provided no impact on duration of the newborns' stay in the intensive care department and general hospital stay; the tendency for mortality reduction in the intensive care department was observed, the duration of APV reduced to statistically significant extend, and this allowed constraining drug resistance of certain nosocomial strains of microorganisms.
About the Authors
G. A. KudinovaRussian Federation
Head of Anesthesiology and Intensive Care Department no. 2.
P. I. Mironov
Russian Federation
Doctor of Medical Sciences, Professor, Head of Pediatric Surgery Department with IDPO Training
I. I. Lutfarakhmanov
Russian Federation
Doctor of Medical Sciences, Professor, Head of Anesthesiology and Intensive Care Department with IDPO Training
References
1. Аleksandrovich Yu.S., Pshenisnov K.V. Intensivnaya terapiya novorozhdennykh. [Intensive therapy of newborns]. St. Petersburg, Izd-vo N-L Publ., 2013, 672p.
2. Vedenie novorozhdennykh s respiratornym distress-sindromom. Klin. rekomendatsii RАSPM pod red. akad. RАN V. V. Volodina. [Management of newborns with respiratory distress syndrome. Clinical guidelines of RASPM edited by V.V. Volodin]. 2016, 48 p.
3. Mironov P.I., Rudnov V.А. Clinical value of monitoring of procalcitonin level in blood during artificial lung ventilation in newborns with respiratory distress syndrome. Vestnik Anasteziol. i Reanimatol., 2015, no. 2, pp. 22-26. (In Russ.)
4. Abbas Q., Ul Haq A., Kumar R. et al. Evaluation of antibiotic use in Pediatric IntensiveCare Unit of a developing country. Indian. J. Crit. Care Med., 2016, vol. 20, no. 5, pp. 39-42.
5. Duflo F., Debon R., Monneret G. et al. Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology, 2002, vol. 96, pp. 74-79.
6. Gerber J.S., Newland J.G., Coffin S.E. et al. Variability in antibiotic use at children’s hospitals. Pediatrics, 2010, vol. 126, no. 6, pp. 1067-1073.
7. Kuppala V.S., Meinzen-Derr J., Morrow A.L. et al. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J. Pediatr., 2011, vol. 159, no. 5, pp. 720-725.
8. Oppert M., Reinicke A., Muller C. et al. Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation, 2002, vol. 53, pp. 167-170.
9. Patel S.J., Saiman L. Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. Clin. Perinatol., 2010, vol. 37, no. 3, pp. 547-563.
10. Sastre J.L., Solis D.P., Seradilla V.R. et al. Procalciotoin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin. BMC Pediatrics., 2006, vol. 6, pp. 1-7.
11. Schulman J., Dimand R.J., Lee H.C. et al. Neonatal intensive care unit antibiotic use. Pediatrics, 2015, vol. 135, no. 5. pp. 826-833.
12. Sweet D.G., Carnielli V., Greisen G. et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants – 2013 Update. Neonatology, 2013, vol. 103, no. 4, pp. 353-358.
Review
For citations:
Kudinova G.A., Mironov P.I., Lutfarakhmanov I.I. EVALUATION OF CLINICAL EFFICIENCY OF RESTRICTIVE TACTICS OF ANTIBACTERIAL THERAPY IN CASE OF UNPROVED INFECTION IN NEONATAL INTENSIVE CARE DEPARTMENT. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2016;13(6):54-58. (In Russ.) https://doi.org/10.21292/2078-5658-2016-13-6-54-58